The survival rate tells you what percent of people live a certain number of years after the cancer is found. Percent means how many out of 100. The survival rate for children with Brain Stem Glioma varies depending on the location of the tumor and other factors.
Approximately 5,270 brain and other Central Nervous System (CNS) Tumors will be diagnosed this year in people younger than 20 in the United States of America.
After leukemia, CNS tumors are the second most common childhood cancers, accounting for about 26% of cancer in children younger than 15.
Almost 11% of all childhood CNS tumors are Brain Stem Gliomas. Approximately 75% to 80% of Childhood Brain Stem Gliomas are in the Pons.
A European Society of Pediatric Oncology (SIOPE) and the International Society of Pediatric Oncology (SIOP) collaborative report, which gathers records of Diffuse Intrinsic Pontine Glioma (DIPG) and was published in July 2018, reveals that the average survival rate in more than 700 cases is 11 months.
As of early-2019, the Instituto de Oncología Intervencionista (Interventionist Oncology Institute) has treated over 70 patients with an average age of 9 years diagnosed with DIPG. After treatment, the median survival is 24 months (Kaplan-Meier). Just over 90 percent of the patients had over 1 year of survival and 50 percent more than 2 years of survival. The Institute continues to advance and improve.
IDOI MEXICO stands out as an institution by virtue of its statistics, since it has 10 percent of the SIOPE and SIOP patient registry, and for obtaining more favorable patient outcomes on average.